ssDNA functionalized nanodiamonds for uranium decorporation

[1]  Juanxiu Xiao,et al.  DNA nano-pocket for ultra-selective uranyl extraction from seawater , 2020, Nature Communications.

[2]  Xuan-yu He,et al.  Ultrasensitive, recyclable and portable microfluidic surface-enhanced raman scattering (SERS) biosensor for uranyl ions detection , 2020 .

[3]  R. Zhou,et al.  A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo , 2019, Nature Communications.

[4]  Kai Yang,et al.  3,2-Hydroxypyridinone-Grafted Chitosan Oligosaccharide Nanoparticles as Efficient Decorporation Agents for Simultaneous Removal of Uranium and Radiation-Induced Reactive Oxygen Species in Vivo. , 2018, Bioconjugate chemistry.

[5]  K. Arunachalam,et al.  Uranium (238U)-induced ROS and cell cycle perturbations, antioxidant responses and erythrocyte nuclear abnormalities in the freshwater iridescent shark fish Pangasius sutchi. , 2017, Aquatic toxicology.

[6]  Kinam Park,et al.  Combinatorial nanodiamond in pharmaceutical and biomedical applications. , 2016, International journal of pharmaceutics.

[7]  Jiye Shi,et al.  One‐Shot Immunomodulatory Nanodiamond Agents for Cancer Immunotherapy , 2016, Advanced materials.

[8]  E. Fattal,et al.  Novel drug delivery systems for actinides (uranium and plutonium) decontamination agents. , 2015, Advanced drug delivery reviews.

[9]  Haiping Fang,et al.  Nanodiamonds act as Trojan horse for intracellular delivery of metal ions to trigger cytotoxicity , 2015, Particle and Fibre Toxicology.

[10]  Chunhai Fan,et al.  The Biocompatibility of Nanodiamonds and Their Application in Drug Delivery Systems , 2012, Theranostics.

[11]  Yan Peng,et al.  Nanodiamonds as intracellular transporters of chemotherapeutic drug. , 2010, Biomaterials.

[12]  Delphine Lecerclé,et al.  Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation. , 2008, European journal of medicinal chemistry.

[13]  Yi Lu,et al.  Highly sensitive and selective colorimetric sensors for uranyl (UO2(2+)): development and comparison of labeled and label-free DNAzyme-gold nanoparticle systems. , 2008, Journal of the American Chemical Society.

[14]  C. Auwer,et al.  Review of actinide decorporation with chelating agents , 2007 .

[15]  S. Sarkar,et al.  Uranium induces oxidative stress in lung epithelial cells , 2007, Archives of Toxicology.

[16]  V. Chaleix,et al.  Synthesis of novel phosphonated tripodal ligands for actinides chelation therapy , 2007 .

[17]  Bing Xu,et al.  A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles to remove uranyl ions from blood. , 2006, Journal of the American Chemical Society.

[18]  E. Fattal,et al.  Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[19]  F. Taran,et al.  Discovery of powerful uranyl ligands from efficient synthesis and screening. , 2005, Chemistry.

[20]  Jide Xu,et al.  Rational design of sequestering agents for plutonium and other actinides. , 2003, Chemical reviews.

[21]  B. Tracy,et al.  Chronic ingestion of uranium in drinking water: a study of kidney bioeffects in humans. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  A. Evan,et al.  Functional basis for the glomerular alterations in uranyl nitrate acute renal failure. , 1985, Kidney international.

[23]  P. Durbin,et al.  Removal of 238Pu(IV) from Mice by Poly-Catechoylate, -Hydroxamate or -Hydroxypyridinonate Ligands , 1989 .